Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Distant metastases from salivary glands cancer
Autore:
Bradley, PJ;
Indirizzi:
Queens Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Nottingham NG1 5EH, England Queens Med Ctr Nottingham England NG1 5EH g, Nottingham NG1 5EH, England
Titolo Testata:
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES
fascicolo: 4, volume: 63, anno: 2001,
pagine: 233 - 242
SICI:
0301-1569(200107/08)63:4<233:DMFSGC>2.0.ZU;2-4
Fonte:
ISI
Lingua:
ENG
Soggetto:
ADENOID CYSTIC CARCINOMA; ACINIC CELL-CARCINOMA; FACTORS INFLUENCING SURVIVAL; DUCT CARCINOMA; MUCOEPIDERMOID CARCINOMA; SUBMANDIBULAR-GLAND; PROGNOSTIC FACTORS; RADIATION-THERAPY; GRADING CRITERIA; MALIGNANT-TUMORS;
Keywords:
distant metastases; salivary gland cancer;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
45
Recensione:
Indirizzi per estratti:
Indirizzo: Bradley, PJ Queens Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, 32A Ropewalk, Nottingham NG1 5EH, England Queens Med Ctr 32A Ropewalk NottinghamEngland NG1 5EH ngland
Citazione:
P.J. Bradley, "Distant metastases from salivary glands cancer", ORL-J OTO R, 63(4), 2001, pp. 233-242

Abstract

Patients who present with malignant salivary glands should at their initial assessment have an X-ray of the chest to exclude the possibility of distant metastases. Patients who have other symptoms, bone pain etc., should be appropriately investigated. The likelihood of patients developing distant metastases is associated with high-grade tumors, most commonly adenoid cystic carcinoma, high-grade mucoepidermoid carcinoma, salivary duct carcinoma and tumors sited in the submandibular gland, posterior tongue and pharyngealtumors. Patients who have had a high-grade tumor treated and survived without locoregional recurrence have the same risk of developing distant metastases as those patients who have locoregional recurrence. Other histologicaltypes of salivary tumors are associated with a lower risk of developing distant metastases but a real risk remains lifelong. It is recommended that all patients who have a malignant salivary gland tumor treated, any histology, should be followed up and clinically assessed at least once every 12 months for life. Copyright (C) 2001 S.Karger AG, Basel.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/09/20 alle ore 05:28:41